What is the other pandemic, a part of Covid-19, that we may face in the near future? Antibioticresistance has big chances to be the one. Pharmacelera, a CataloniaBio & HealthTech member, will organise the open discussion Antimicrobial resistance: phenotypic vs target-based screening on 9 July with.

Three experts in the field will share their experience in the search for new strategies for the discovery of antibiotics:

• Eric Bacqué, VP Chemistry & AMR Portfolio Coordinator of Evotec
• Santanu Datta, co-founder and CSO of Bugworks Research Inc.
• Marc Gitzinger, co-founder and CEO of BioVersys
• Albert Palomer, board member of Pharmacelera

Language: English

Registration: free of charge

More information